Chia Fei Biological: Improved Ankara smallpox vaccine virus monkeypox attenuated live vaccine obtains clinical trial approval letter.

Chia Tai Bio announced that its wholly-owned subsidiary, Chia Tai Longke, independently developed a modified Ankara smallpox vaccine virus monkeypox attenuated live vaccine, which has obtained the Drug Clinical Trial Approval Notice from the National Medical Products Administration, allowing the product to conduct clinical trials for the prevention of monkeypox disease caused by monkeypox virus in individuals aged 18 and above.